chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pts arm was red hot and swollen from shoulder to mid arm. recommended motrin, benadryl and an ice pack
Dizziness. BP 98/44 (pulse 74); 90/56 (pulse, 86)
About 5 minutes after the injection,  employee reported having had tickling/itching in throat, facial flushing, and tachycardia. A rapid response was called, and was given Benadryl. She was brought to ED for monitoring and treatment, where she received more Benadryl + Famotidine. After receiving the medications, symptoms subsided, and she was discharged home.
At this time I have a permanent rash in my left hand, stomach burn fluid, for the stomach give me some prescription (omaproxen) and for my rash give me Calamine I still with the problem. I have 4 shots of anthrax.
ear fullness-went to ent was given antibiotics but ear fullness remains now tinnitus is starting to happen.  Went to an acupuncturist a few times but issue remains at the same time the ear fullness started, my right hip was sore (previous orthoscopic hip surgery june 2020) made an appointment for the orthopedic and received my second shot while waiting for the appointment.  Woke up after second shot with throbbing pain the the hip.   The intensity has declined but the constant pain persists.  Orthopedic prescribed Meloxicam which has dulled the pain but again it remains
Syncope 8/28/20 and feeling dizzy for the past 2-3 days
Pt received seasonal flu shot at 3pm and around 6 pm, he started getting chills, began feeling fatigued and not well. He left work early. Developed headache, muscle aches, a fever (100.8), stronger chills, red eyes and intense fatigue. Heart was racing, labored breathing and stomach felt sick.
1237 Pt complained she felt "off center"   1300 BP 140/80, )2 98%, HR 58, 1325 She felt better vs no change. She ride home with her sister
Suspected febrile seizure, fever, vomiting, spasms of muscles and then sever shaking/chills for approximately 15 minutes. Transported to hospital by ambulance at approximately 1am. Discharged at 5:30am after monitoring.
This spontaneous report as received from a pharmacy technician refers to a 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported. On 08-FEB-2018 the patient was vaccinated with improperly stored dose of Oka/Merck VARIVAX (lot # N022979, expiry date: 23-AUG-2019) (dose, frequency and route were not reported) for prophylaxis. No adverse effect was reported. The Oka/Merck VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1802USA001558.
I did not have memory loss prior to the COVID-19 vaccine. Began to notice my near photographic memory was fuzzy about 2 months after the vaccine. Six months later, could remember everything prior to vaccine. Last two months was fuzzy. Everything from vaccine to month 4 was gone. After getting the J&J booster Nov 2021, my memory was gone from the date of the first vaccine, through the booster, and remains that today. This is like being 45 and having Alzheimer's or dementia. Many times, I cannot remember if I just took my medication or even left the tea kettle on. Luckily, the tea kettle has a whistle.
Patient developed a rash on the forehead approximately 3-4 days after the shot. Took over the counter BENADRYL for 2 days then rash went away.
she fell/ended up on the floor; cold sweat; shakes were a little bit better/hard shakes; couldn't get warm; chills; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 71-year-old female patient received bnt162b2 first dose of (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) as single dose, administered in Arm Right on 05Mar2021 13:00 (at the age of 70-year-old), as dose 1, single for covid-19 immunisation. The Medical history and concomitant medications were not reported. No family history reported. No prior Vaccinations (within 4 weeks). On 22Mar2021 patient experienced chills, fever, shakes were a little bit better/hard shakes, couldn't get warm and on 23Mar2021 she fell/ended up on the floor, cold sweat. It was reported that scheduled to receive the second dose of the Pfizer-BioNTech COVID-19 Vaccine today, 25Mar2021. Last Monday, 22Mar2021, Caller reported to have had chills, fever (all day until night) Caller had 2 blankets on, and heaters. Caller also mentioned that she fell, and that yesterday, the shakes were a little bit better but she also had a high fever. Reports on Monday she had hard shakes, could not get warm; this went on for several hours then at midnight it went the opposite and she broke out with a cold sweat. Her temperature was 101.2. Adds on Tuesday, late afternoon the same thing happened, she had hard shakes with chills and her temperature was 101.4; then she went to the bathroom and she does not know what happened next but she ended up on the floor. Adds then Wednesday the chills and shakes were less but she still had a 102. Fever. Now she is asking for a should she get the next shot or can she wait. Clarifies she had the first dose of the Pfizer COVID 19 vaccine on 05Mar2021 at 1300 pm in the right arm. She is scheduled for the second dose today on 25Mar2021 but she does not think she can make it. Patient did not visited Emergency Room or Physician Office. The patient underwent lab tests and procedures which included body temperature: 101.2 on an unspecified date and body temperature wass101.4 on 23Mar2021 , body temperature: 102 on 24Mar2021. The outcome of event recovering for hard shakes, Chills and Fever, cold sweat was not Recovered, she fell/ended up on the floor was Recovered on 23Mar2021.  No follow-up attempts are possible. No further information is expected.
Pt had fever, chills, sore throat and nausea. No redness or edema at injection site. States "achey feeling all over." Instructed to see PMD. Took BC for fever and achy feeling. Instructed to take Tylenol for fever.
Patient received Moderna first dose (lot 016B21A) on 5/4/21.  Received Pfizer dose as noted above on 6/12/21.  No adverse events, but reporting per protocol.  There was a language barrier with the patient which led to confusion and him receiving two different iterations of COVID vaccine.  Patient did not show any adverse reactions and was instructed to follow up with primary care physician for further guidance.
Stated by patient, experienced burning sensation around mouth and sharp throbbing pain on back of the head.
headache; soreness to the arm; Too late to get the second dose; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not available), via an unspecified route of administration on 11Jan2021 (at the age of 68-years old) at a single dose for COVID-19 immunization. Medical history included respiratory disorder from Dec2020 and ongoing. Concomitant medications were not reported. The patient received the first dose and stated that she only had a headache and soreness to the arm on an unspecified date. The patient was at the ENT being checked for a respiratory infection when she was contacted to make her second dose appointment. She had the respiratory problem since December and had made the appointment for the ENT prior to the first dose of the vaccine. She confirmed that she was not diagnosed with a respiratory infection. She was told to reschedule her second dose appointment which was originally scheduled for 01Feb2021, but she asked the pharmacy and was told that it was too late to get the second dose. She wanted to know if she can get the second dose after six weeks. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Around 9/8/09 noticed a "spot" on chest then came down w/fever and cold symptoms on or around 9/15/09. Then the week of 9/21/09 began w/a rash on skin and itching. Rash got worse on 9/22/09. She saw her doctor on 9/22/09. Doctor dx'd as: "pityriasis rosea" and gave ERYTHROMYCIN and antihistamine.
Brain fog, migraines, confusion, nausea, vomiting, diarrhea, extreme muscle pain, chills, vertigo.
pt recv vax 22MAY95 & 01JUN95 pt exp a rash less than 20 lesions; No further details were provided;
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (she has been very sick since she got the vaccine) and GENERAL PHYSICAL HEALTH DETERIORATION (they just want to report that she going to die quickly because she has been very sick since she got the vaccine) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (she has been very sick since she got the vaccine) and GENERAL PHYSICAL HEALTH DETERIORATION (they just want to report that she going to die quickly because she has been very sick since she got the vaccine). At the time of the report, ILLNESS (she has been very sick since she got the vaccine) and GENERAL PHYSICAL HEALTH DETERIORATION (they just want to report that she going to die quickly because she has been very sick since she got the vaccine) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported. No treatment drug was reported.   Reporter did not allow further contact
14 month old male in normal state of health presented with acute onset generalized ataxia with inability to walk or crawl.  No prodromal symptoms.  He had first DTaP vaccine one week prior to onset.  Evaluated by 2 physicians in ER.  Child had normal extensive labs + normal MRI.  Symptoms gradually resolved over next 24 hours.
On 06/12/2003 child brought to clinic by mom presenting with swollen left deltoid, warm to touch and somewhat painful. Mom given option of appt on 06/12/2003 and but she elected to wait and see if child would improve. If not improving, would make appt condition. Dr. asked RN to evaluate: suggestion make for use of ice packs, Tylenol, rt clinic PRN.
Approximately 5 minutes after vaccine, patient started to pass out...was leaning on mother in waiting area.  Patient was then transferred to floor to lay flat with knees bent and immediately felt better, stating, "I can see now."  She mentioned feeling warm, so outer sweatshirt was taken off and cool water bottle applied to back of neck.  She was subsequently given water and some orange juice as she had not eaten all morning.  Her BP was 106/70 with pulse 60.  Paramedics arrived and took her to ED for further observation.
Woke up at 3am with shooting pains in my arm back and neck. Had a bad headache and was nauseous.  I got up and took a Tylenol, went back to bed and woke up 2 hrs. later with the same side effects.  I could not eat, tried to drink as much as possible and continued to have extreme cramping all over my body as well as chills, sweats, nausea and light headedness.  I did not run a fever, but was unable to get off  the couch and do normal activities until the next morning.  I continued to take Tylenol for 3 days  but had a low grade headache and backache for a number of days.  I have not been this sick for years.  Glad the severity only lasted a day and a half.  Im still struggling with back pain 3 days later.
Side effects of severe flu like symptoms for 2 days.  Fatigue and moderate headache are still going on post 1 week after vaccine.  Headache is constant dull pain.  Fatigue is moderate but starting to interfere with daily tasks
c/o "Spinning sensation" in head-no other symptoms. Radial pulse 86 and regular B/P 142/82. No change in symptom x 45 min. Instructed by RN to go to ER if symptom worsened or new symptoms (SOB, wheezing dizziness, weakness swollen throat) developed. Refused to go to ER at time of event. Checked (15m x 4'5m 11-8-07-TC: "spinnin symptom resolved at 10pm on 11-7-07 feels fine today.
21 days exactly after I received my final Covid-19 dose, my lip started suddenly swelling. I woke in the early morning with a swollen lip. I took about 3 doses of Benadryl before it finally went down. After awhile the Benadryl no longer worked. So my asthma dr. prescribed my Prednisone. Every time my lip or tongue started to swell I had to take three 10 mg Prednisone. The swelling kept occurring for up to approx. 5 months. Then finally subsided. I know it was the vaccine because in all my years of being an asthmatic and having allergies, never ever have I ever had a swelling episode from anything. And I do not have lip fillers. Also, I read an article about a woman who experienced the same symptoms of swelling lips exactly 3 weeks after her 2nd dose of the Pfizer vaccine. So I'm pretty sure that lip swelling is a side effect of the Covid-19 vaccine, even in people like myself who have no lip fillers.
This spontaneous report was received from registered nurse, referring to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX lot # L039092 with expiry date on 06-OCT-2017, and lot # L040423 with expiry date on 15-OCT-2017 (strength, dose, frequency, anatomical location and route were not reported). No product quality complaint was involved. Additional information has been requested.
pt recv vax 15JUN95 & 17NOV97 pt devel red marks on stomach & back axilla w/no fever;pt was dx w/varicella zoster;
Severe chills, mild-to-moderate fever, muscle aches, joint aches, mild headache.
Redness and swelling at injection site after injection, approx 30 sec-1 min after. TX w/ ice pack; observed patient in waiting area x 30 min. Swelling/redness subsided. Called pt to follow up in evening, completely resolved.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/11/2021 and 3/11/2021. Presented to ED on 9/19/2021 with a 6 day history of cough and worsening shortness of breath. On admission was hypoxic on room air that improved with 5 L of oxygen via nasal cannula. Patient was treated with dexamethasone, remdesivir, and baricitinib. Ultimately had progressive hypoxemia requiring mask BiPAP making it difficult to eat or drink and on the evening of 9/30 was intubated.  Over the next 7 days he continued to deteriorate with worsening hypoxemia requiring prone ventilation strategy.  Despite maximization of ventilator efforts he never improved.  Moreover, he developed persistent hypotension and renal failure with minimal urine output ultimately with acidosis and hyperkalemia.  Palliative care was involved with family discussions.  He was transitioned to DNR status and expired on 10/6/2021.
Patient states she is experiencing numbness in arm and hand. States a nerve was hit . (patient has history of spinal stenosis, and walks with a cane)
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 64-year-old patient received BNT162b2, on 16Oct2021 as dose number unknown, single (Batch/Lot number: unknown), in right arm, on 09Apr2022 as dose number unknown, single (Batch/Lot number: unknown) and on 12Apr2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "Known allergies: Sulpha drugs" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; SYNTHROID, both in two weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Patient received paxlovid (lot number: GC0618) from 30Jun2022 to 04Jul2022 for COVID 19 treatment. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
24 hours after DTaP (5th dose) large swelling left thigh red, hard and warm to touch 17.5 cm x 10 cm went to urgent care and started on Keflex.
A pharmacist reported that a pt (age and gender unspecified) received injections of Pnu-Imune 23 and Flu Shield (2000-2001 Formula) on 1/19/01. On an unspecified date, the pt developed an injection site reaction at the Pnu-Imune 23 site described as "a large red wheal, 3" in diameter that became sore, radiating down to the elbow". Note: This is 1 of 2 pts reported by the same reporter. See HQ6999308FEB2001 for the report on the other pt.
Pt recv vax on 11/16/98; on 11/17/98 pt exp red, hot, edema, pain of LA; tx=Cortisone injection, Advil, moist heat
pt recvd flu vax & devel redness, edema, & hardness @ inj site; Medical Affairs comment: inj was given SC; flu Shield is labelled for IM inj;
PNEUMOVAX 23 is accidentally given a third time to a patient; No additional adverse effects; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's medical history, concurrent conditions or concomitant medication. The pharmacist asked for information if the system did not show complete vaccination system and the patient was vaccinated accidentally with a third dose, reported as a third time of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), dose: 0.5 milliliter, for prophylaxis, on an unknown date. (route of administration, lot number and expiration date were not reported) (Extra dose administered). No additional adverse event reported. No product quality complaint.
pt recvd vax;began to exp n & v along w/ sxs of the flu;sxs cont until death;pt did not seek med help;cause of death cardiac tamponade due to ruptured myocardial infarction & coronary atherosclerosis;
I experienced burning, itchy eyes and blurry vision within just a few minutes of receiving the vaccine.  For ~ three weeks after receiving the vaccine I experienced eye soreness which made it difficult to sleep.  I continue to experience a burning sensation, eye dryness, and sensitivity to bright light in both eyes to this day (41 days post vaccination).
Has to take her time so that she does not fall, she can use her knees; weakness/feeling weak from her waist down/When she got ready to get in a chair she could not pull herself up; She could not use her knees; Unable to write clearly; not able to stand up; Had to crawl; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported for herself that:  An 87-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: ELS263, Expiry date was not reported) via an unspecified route of administration on 22Feb2021 in the left shoulder/arm left at 12:00 (at the age of 87 years old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included High blood pressure from 2000 and ongoing. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on 01Feb2021 (at the age of 87-years-old) as DOSE 1, SINGLE for covid-19 immunisation/ first dose was administered 3 weeks before second dose approximately 01Feb2021. There were no concomitant medications. The patient has not received any other products. On 23Feb2021 she had onset of feeling weak from her waist down; unable to write clearly (unable to write checks), was not able to stand up, had to crawl, when she got ready to get in a chair, she could not pull herself up; she could not use her knees. Patient takes her time so that she does not fall, she can use her knees on 24Feb2021. She asked for information on why these events occurred relative to the Pfizer COVID-19 Vaccine. Patient stated that there has been no emergency room visit, hospitalization or physician's office visit relative to any of the adverse events reported. Patient has not received any investigation assessment. The clinical outcome of the event has to take her time so that she does not fall, she can use her knees was recovering while other events recovered with sequel.   No follow-up attempts are possible. No further information is expected.
About 25 minutes after receiving the injection I started to experience chest pain. It did not go away after several hours. I went to the ER and had several tests done including a ECG 12-LEAD and chest x-rays. I was later prescribed an anti-inflammatory for the inflammation of the heart (Myocarditis).
child woke up and came downstairs, started raging over nothing.  Found him to be running low grade fever 100, chest congestion, cough, nose congestion.  Child has not recovered.  Began displaying behavioral difficulties of irritability, tantrums, raging, severe separation anxiety, personality changes, none of which were present before the vaccination
He would not sleep, would not eat, every time he layed down he would let out a high pitched squill and cry for hours. He would stare of into space and be non responsive.
Above  colarbone lymph node swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Aug2021 at 09:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Aug2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 28Aug2021 at 02:00, the patient experienced above colarbone lymph node swollen. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event above colarbone lymph node swollen was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.